MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities
(note 4)
$491,265K
Cash and cash
equivalents
$357,011K
Prepaid expenses and
other current assets
$22,938K
Total current assets
$871,214K
Marketable securities,
non-current (note 4)
$771,158K
Property and equipment,
net (note 6)
$43,175K
Right-of-use assets,
operating leases
$42,351K
Other non-current
assets
$9,114K
Restricted cash
$5,800K
Total assets
$1,742,812K
Total liabilities and
stockholders' equity
$1,742,812K
Total stockholders'
equity
$1,579,664K
Total liabilities
$163,148K
Accumulated deficit
-$1,065,961K
Additional paid-in capital
$2,643,817K
Total current
liabilities
$83,212K
Operating lease
liabilities, net of current...
$67,034K
Deferred revenue, net of
current portion
$11,440K
Finance lease
liabilities, net of current...
$1,462K
Accumulated other
comprehensive income (loss)
$1,800K
Common stock, 0.0001
par value...
$8K
Accrued expenses (note
8)
$42,274K
Deferred revenue
$22,925K
Operating lease
liabilities
$11,941K
Accounts payable
$4,015K
Finance lease
liabilities
$1,815K
Other current
liabilities
$242K
Back
Back
Balance Sheet
source: myfinsight.com
Kymera Therapeutics, Inc. (KYMR)
Kymera Therapeutics, Inc. (KYMR)